Different effect of psyllium and guar dietary supplementation on blood pressure control in hypertensive overweight patients: A six-month, randomized clinical trial

Clinical and Experimental Hypertension

Volumn 29, Issue 6, 2007, Pages 383-394

  Cicero, Arrigo F G ^a,c   Derosa, Giuseppe ^b   Manca, Marco ^a   Bove, Marilisa ^a   Borghi, Claudio ^a   Gaddi, Antonio V ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b UNIVERSITY OF PAVIA   (Italy)

^c UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Hypercholesterolemia; Hyperglycemia; Hypertension; Overweight; Soluble fibers

Indexed keywords

ANTIHYPERTENSIVE AGENT; APOLIPOPROTEIN B; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; GLUCOSE; HEMOGLOBIN A1C; ISPAGULA; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ARTICLE; BLOATING; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE REGULATION; BODY MASS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DIET SUPPLEMENTATION; DIETARY FIBER; DRUG EFFECT; FEMALE; GLUCOSE HOMEOSTASIS; GUAR; HEMOGLOBIN DETERMINATION; HIGH FIBER DIET; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; OBESITY; RANDOMIZED CONTROLLED TRIAL; THERAPY EFFECT; TREATMENT OUTCOME; TREATMENT RESPONSE;

AGED; ANTI-OBESITY AGENTS; BODY MASS INDEX; CATHARTICS; DIETARY FIBER; GALACTANS; HUMANS; HYPERTENSION; LIPID METABOLISM; MANNANS; MATCHED-PAIR ANALYSIS; MIDDLE AGED; OVERWEIGHT; PLANT GUMS; PSYLLIUM;

EID: 34548321367     PISSN: 10641963     EISSN: 15256006     Source Type: Journal    
DOI: 10.1080/10641960701578378     Document Type: Article

References (44)

1. Pearson TA, Bazzarre TL, Daniels SR, Fair JM, Fortmann SP, Franklin BA, et al. American Heart Association guide for improving cardiovascular health at the community level. Circulation 2003;107:645-651.
2. Forman D, Bulwer BE. Cardiovascular disease: Optimal approaches to risk factor modification of diet and lifestyle. Curr Treat Options Cardiovasc Med. 2006;8(1):47-57.
3. He J, Klag MJ, Whelton PK, Chen JY, Qian MC, He GQ. Dietary macronutrients and blood pressure in south-western China. J Hypertens. 1995;13:1267-1274.
4. Stamler J, Caggiula A, Granditz GA. Relationships of dietary variables to blood pressure (BP): findings of the Multiple Risk Factor Intervention trial. Circulation 1992;85:867-875.
5. Stamler J, Caggiula AW, Grandits GA. Relation of body mass and alcohol, nutrient, fiber, and caffeine intakes to blood pressure in the special intervention and usual care groups in the Multiple Risk Factor Intervention Trial. Am J Clin Nutr. 1997;65:338-365.
6. Streppel MT, Arends LR, van 't Veer P, Grobbee DE, Geleijnse JM. Dietary fiber and blood pressure. A meta-analysis of randomized placebo-controlled trials. Arch Intern Med. 2005;165:150-156.
7. Ascherio A, Rimm EB, Giovanucci EL, Colditz GA, Rosner B, Willett WC, Sacks F, Stampfer MJ. A prospective study of nutritional factors and hypertension among US men. Circulation 1992;86:1475-1484.
8. WHO. Population nutrient intake goals for preventing diet-related chronic diseases. In: Diet, nutrition and the prevention of chronic diseases. WHO Technical report Series 2003;916:46-83.
9. Eastwood MA, Passmore R. Dietary fiber. Lancet 1983;2:202-206.
10. Brown L, Rosner B, Willett WW, Sacks FM. Cholesterol-lowering effects of dietary fiber: a meta-analysis. Am J Clin Nutr. 1999;69:30-42.
11. Truswell AS. Dietary fiber and plasma lipids. Eur J Clin Nutr. 1995;49(Suppl):S105-S109.
12. Glore SR, Van Treeck D, Knehans AW, Guild M. Soluble fiber and serum lipids: a literature review. J Am Diet Assoc. 1994;94:425-436.
13. Kris-Etherton PM, Krummel D, Russell ME. The effect of diet on plasma lipids, lipoproteins, and coronary heart disease. J Am Diet Assoc. 1988;88:1373-1400.
14. Delargy HJ, O'Sullivan KR, Fletcher RJ, Blundell JE. Effects of amount and type of dietary fiber (soluble and insoluble) on short-term control of appetite. Int J Food Sci Nutr. 1997;48(1):67-77.
15. Racette SB, Deusinger SS, Deusinger RH. Obesity: overview of prevalence, etiology, and treatment. Phys Ther. 2003;83(3):276-288.
16. Hense HW. Once at risk - forever at risk? The long-term impact of cardiovascular risk factors on death. Eur J Epidem. 2004;19:409-410.
17. Galisteo M, Sanchez M, Vera R, Gonzalez M, Anguera A, Duarte J, Zarzuelo A. A diet supplemented with husks of Plantago ovata reduces the development of endothelial dysfunction, hypertension, and obesity by affecting adiponectin and TNF-alpha in obese Zucker rats. J Nutr. 2005;135(10):2399-2404.
18. Cifkova R, Erdine S, Fagard R, Farsang C, Heagerty AM, Kiowski W, Kjeldsen S, Luscher T, Mallion JM, Mancia G, Poulter N, Rahn KH, Rodicio JL, Ruilope LM, van Zwieten P, Waeber B, Williams B, Zanchetti A; ESH/ESC Hypertension Guidelines Committee. Practice guidelines for primary care physicians: 2003 ESH/ESC hypertension guidelines. J Hypertens. 2003;21(10):1779-1786.
19. WHO. Preventing and managing the global epidemic of obesity. Report of the World Health Organization Consultation of Obesity. WHO, Geneva, June 1997.
20. Krauss RM, Eckel RH, Howard B, Appel LJ, Daniels SR, Deckelbaum RJ, Erdman JW Jr, Kris-Etherton P, Goldberg IJ, Kotchen TA, Lichtenstein AH, Mitch WE, Mullis R, Robinson K, Wylie-Rosett J, St Jeor S, Suttie J, Tribble DL, Bazzarre TL. AHA dietary guidelines: revision 2000. A statement for healthcare professionals from the Nutrition Committee of the American Heart Association. Circulation 2000;102(18):2284-2299.
21. Gaddi A, Cicero AFG, Dormi A, Pasquarelli V, S. D'Addato S. The realisation of a project aimed at reducing the plasmatic lipid level in a large Italian rural population improves the mean calcium daily intake: the Brisighella Study. Eur J Clin Nutr. 2001;55(2):97-106.
22. Luepker RV, Murray DM, Jacobs DR Jr, Mittelmark MB, Bracht N, Carlaw R, Crow R, Elmer P, Finnegan J, Folsom AR. Community education for cardiovascular disease prevention: risk factor changes in the Minnesota Heart Health Program. Am J Public Health. 1994;84:1383-1393.
23. 2+ precipitation procedure for quantitation of high-density-lipoprotein cholesterol. Clin Chem. 1982;28:1379-1388.
24. European Diabetes Policy Group. A desktop guide to type 2 diabetes mellitus. Diab Med. 1999;16:716-730.
25. Heding LG. Determination of total serum insulin (IRI) in insulin-treated diabetic patients. Diabetologia 1972;8:260-266.
26. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412-419.
27. nd ed., pp. 139-144. Hamilton, Canada: B.C. Decker Inc., 2000.
28. The EUROASPIRE Study Group. Clinical reality of coronary prevention guidelines: a comparison of EUROASPIRE I and II in nine countries. Lancet 2001;357:995-1001.
29. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III): Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001;285:2486-2497.
30. Carson JA. Nutrition therapy for dyslipidemia. Curr Diab Rep. 2003;3(5):397-403.
31. Brown L, Rosner B, Willett WW, Sacks FM. Cholesterol-lowering effects of dietary fiber: a meta-analysis. Am J Clin Nutr. 1999;69:30-42.
32. Slavin JL, Greenberg NA. Partially hydrolyzed guar gum: clinical nutrition uses. Nutrition 2003;19(6):549-552.
33. Grundy SM, Hansen B, Smith SC Jr, Cleeman JI, Kahn RA, for Conference Participants. Clinical management of metabolic syndrome. Report of the American Heart Association/National Heart, Lung, and Blood Institute/American Diabetes Association Conference on Scientific Issues Related to Management. Circulation 2004;109:551-556.
34. Pittler MH, Ernst E. Dietary supplements for body-weight reduction: a systematic review. Am J Clin Nutr. 2004;79(4):529-536.
35. Whelton SP, Hyre AD, Pedersen B, Yi B, Whelton PK, JE. Effect of dietary fiber intake on blood pressure: a meta-analysis of randomized, controlled clinical trials. J Hypertens. 2005;23:475-481.
36. Menotti A, Lanti M, Agabiti-Rosei E, Carratelli L, Cavera G, Dormi A, Gaddi A, Mancini M, Motolese M, Muiesan ML, Muntoni S, Muntoni S, Notarbartolo A, Prati P, Remiddi S, Zanchetti A. Riskard. New tools for prediction of cardiovascular disease risk derived from Italian population studies. Nutr Metab Cardiovasc Dis. 2005;15(6):426-440.
37. Oliver SD. The long-term safety and tolerability of ispaghula husk. J R Soc Health. 2000;120(2):107-111.
38. Knopp RH, Superko HR, Davidson M, Insull W, Dujovne CA, Kwiterovich PO, Zavoral JH, Graham K, O'Connor RR, Edelman DA. Long-term blood cholesterol-lowering effects of a dietary fiber supplement. Am J Prev Med. 1999;17(1):18-23.
39. Burke V, Hodgson JM, Beilin LJ, Giangiulioi N, Rogers P, Puddey IB. Dietary protein and soluble fiber reduce ambulatory blood pressure in treated hypertensives. Hypertension 2001;38:821-826.
40. Sierra M, Garcia JJ, Fernandez N, Diez MJ, Calle AP. Therapeutic effects of psyllium in type 2 diabetic patients. Eur J Clin Nutr. 2002;56(9):830-842.
41. Anderson JW, Allgood LD, Turner J, Oeltgen PR, Daggy BP. Effects of psyllium on glucose and serum lipid responses in men with type 2 diabetes and hypercholesterolemia. Am J Clin Nutr. 1999;70(4):466-473.
42. Turnbull WH, Thomas HG. The effect of a Plantago ovata seed containing preparation on appetite variables, nutrient and energy intake. Int J Obes Relat Metab Disord. 1995;19(5):338-342.
43. Landin K, Holm G, Tengborn L, Smith U. Guar gum improves insulin sensitivity, blood lipids, blood pressure, and fibrinolysis in healthy men. Am J Clin Nutr. 1992;56(6):1061-1065.
44. van Nieuwenhoven MA, Kovacs EM, Brummer RJ, Westerterp-Plantenga MS, Brouns F. The effect of different dosages of guar gum on gastric emptying and small intestinal transit of a consumed semisolid meal. J Am Coll Nutr. 2001;20(1):87-91.